Coronavirus

As Americans endure the privations necessary to “flatten the curve” of new cases of coronavirus COVID-19, we wish that our leaders could manage even a fraction of the comity and tolerance exhibited every day by ordinary people throughout this country. Sadly, we see too much of the opposite. Putting aside the machinations of politicians, there seems to be a widespread need to blame any misstep, or even uncertainty, on somebody or something. The ubiquitousness of social media and the internet drives the...

Sally C. Pipes joined the the Pat Miller Show in Cincinnati, Ohio to discuss the enormous benefits of the American private sector in the fight against the coronavirus epidemic. Pipes breaks down how the private sector industries in the United States are pushing innovations in the fight against the coronavirus epidemic including necessary equipment and medical innovation. Click here to listen to the entire interview. ...

The nationally-syndicated Lars Larson Show brings back Dr. Henry Miller for his weekly appearance on updates and discussion on the novel coronavirus pandemic. Lars Larson and Dr. Miller look at the defective tests that many countries like the United Kingdom bought from China and how internal flawed testing in the United States led to a slow response to the coronavirus in the United States. ...

Dr. Henry Miller continues his regular appearance on the John Batchelor Show to discuss updates with the coronavirus pandemic. Dr. Miller talks about case studies from previous vaccines, and breaks down the different stages of testing a coronavirus vaccine including a safety study, random and placebo testing, and a larger controlled test group to ensure the vaccine is safe and how the Gates Foundation is helping to build large-scale manufacturing facilities for some of the vaccines being tested. Click here to...

In response to the coronavirus outbreak, the Centers for Medicare and Medicaid Services has rolled back regulations on hospitals and health care providers. Hospitals are no longer barred from treating COVID-19 patients in outpatient facilities. The feds are also freeing nurse practitioners, physician assistants and medical residents to provide more care on their own. CMS is even issuing waivers that allow hospitals to provide meals, laundry service and child care while health care personnel are working. Apparently, it takes a pandemic for policymakers to acknowledge that so...

PRI Senior Fellow in Health Care Studies Dr. Henry Miller joins PRI's Next Round podcast with an update on the fight against the coronavirus. He offers much-needed perspective on what public health officials are doing to “flatten the curve,” efforts to find vaccines and treatments, the efforts of other countries to contain the virus, when we can expect to get back to business as usual, and whether we should expect more viruses like these going forward. https://youtu.be/1FlElnaB3Ps...

The Centers for Disease Control and Prevention (CDC) has issued guidance for healthcare facilities in response to the COVID-19 virus including asking all U.S. healthcare facilities to “explore alternatives to face-to-face triage and visits.” The CDC has issued this recommendation to help contain the spread of the virus, protect healthcare workers from unnecessary exposure, and protect the health of patients who do not require face-to-face medical visits (particularly patients with underlying health issues including those with heart, kidney and weakened immune systems). In light...

The new coronavirus outbreak has put enormous pressure on the American health care system. In response, federal officials and private insurers have rushed to improve patient access to video consultations and other forms of virtual care. It may have taken a public health emergency to bring “telehealth” to the mainstream, but these services are nothing new. We would do well to expand our reliance on telehealth long after COVID-19 is behind us. Telehealth involves the use of technology to deliver medical care...

As the outbreak of the novel coronavirus continues to gain momentum in the United States, there is intense interest in the development of a vaccine. Several US drugmakers have begun working on a vaccine, independently or with federal agencies like the National Institutes of Health. The public is hungry for news about vaccines, and progress on their development is, at times, exaggerated. Fox Business reported: “We were able to rapidly construct our vaccine in a matter of about three hours once we had...

The federal government’s efforts to combat the ongoing coronavirus pandemic illustrate why we shouldn’t put our full trust in government to find a cure. After all, they badly botched the testing, costing valuable time in identifying new cases and limiting its spread. Fortunately, private-sector innovators are leading where government has underwhelmed, conducting speedy research and development into potentially life-saving cures, while providing critical support in other areas where government action was lacking. The first version of test kits from the Centers for...

Title: COVID-19 Pandemic Delaying Treatments of Hematologic Cancers By: John Schieszer Institutional restrictions due to the coronavirus disease 2019 (COVID-19) pandemic are taking a large toll on patients with hematologic cancers. Some medical centers have canceled treatments and all centers have altered their policies and procedures. Starting in March, elective and semielective surgical procedures at most hospitals throughout the United States were put on hold, and uncertainty remains regarding when these procedures will start up again. . . . . . Because there is...

For anyone following the COVID-19 pandemic – and who isn’t? – it’s evident that we’re awash in punditry, speculation, and modeling. But we two are Massachusetts Institute of Technology graduates, and we’re looking past the noise to what critical data we don’t yet have that will affect the management of the outbreak – which will, in turn, affect both public health and our economic recovery. On the medical front, let’s consider what we do know. First and foremost, the situation in the...

Private pharmaceutical companies and the National Institutes of Health have outdone themselves. Thanks to the funding provided by the NIH, a Phase 1 clinical trial for a COVID-19 vaccine  is underway. In separate efforts, Inovio, Sanofi, Vaxart, GlaxoSmithKline, and Johnson & Johnson are all developing potential vaccines. In total, “about 35 companies and academic institutions are racing to create a vaccine, at least four of which already have candidates they have been testing in animals. The first of these – produced by Boston-based...

As scientists race to develop vaccines and treatments for COVID-19, Democrats in Congress have renewed their push for price controls on drugs designed to protect us from the respiratory disease caused by the coronavirus, along with other illnesses. The Democrats claim many Americans will only be able to afford the therapies that emerge if the government caps their prices. But price controls are a counterproductive way to bring down the cost of vaccines and drugs to treat diseases. They'd not only result in shortages...